Medicine News and Research

RSS

AAA approves guidelines to accept donation of bodies for education and biomedical research

The Board of Directors of the American Association of Anatomists (AAA) has approved a set of guidelines to govern programs accepting the donation of bodies for education and biomedical research. The guidelines cover the minimum requirements that should be met by any Willed Body Program.

11 Mar 2010

Scientists identify specific causative genetic mutation associated with CMT

Scientists using advanced genomic analysis technologies from Life Technologies Corporation have sequenced an individual’s genome and identified the specific causative mutation associated with Charcot-Marie-Tooth Disease (CMT), one of the most common inherited neurological disorders currently affecting 1 in 2,500 individuals in the United States.

11 Mar 2010

Molecular master switch plays a key role in maturation process of brain cells

About four out of every 10 cells in the brain are so-called oligodendrocytes. These cells produce the all-important myelin that coats nerve tracts, ensuring fast, energy-efficient transmission of nerve impulses.

11 Mar 2010

Forteo therapy may speed healing, improve patient outcomes after rotator cuff surgery

Tears in the shoulder's rotator cuff, a common sports injury, are painful and restricting. Surgery to repair the damage is successful for pain management, but in many patients it does not result in full recovery of function due to poor healing. New research shows an approved therapy for osteoporosis, Forteo, may speed healing and improve patient outcomes.

11 Mar 2010

Insight Imaging commences operations in partnership with ARA in the Dallas metro-area

InSight Health Services Holdings Corp. announced today that it has commenced operations in partnership with American Radiology Associates, P.A. in the Dallas metro-area. Insight Imaging will manage the partnership, which has acquired ARA’s Willowbend Diagnostic Imaging Center. ARA has also agreed to provide professional services in the coming months at Insight Diagnostic Center – Forest Lane.

11 Mar 2010

ABH to host three events featuring Dermagraft at DF Con 2010

Advanced BioHealing, Inc., a leader in commercializing the promise of regenerative medicine, announced that it will host three events featuring the Company’s lead product, Dermagraft® at this year’s Diabetic Foot Global Conference (DF Con) 2010, the largest annual interdisciplinary diabetic foot conference in North America.

11 Mar 2010

RTI Biologics launches BTB Select and BioCAP Select implants for use in sports medicine surgeries at AAOS 2010

RTI Biologics Inc., the Florida-based processor of orthopedic, dental, surgical specialties and other biologic implants, is launching two new biologic implants for use in sports medicine surgeries at the American Academy of Orthopaedic Surgeons annual meeting in New Orleans this week.

11 Mar 2010

New study shows e-prescriptions reduce medication errors

Is it time for all community-based doctors to turn to e-prescribing to cut down on the number of medication errors? According to Rainu Kaushal and colleagues from the Weill Cornell Medical College in New York, electronic prescriptions can dramatically reduce prescribing errors - up to seven-fold.

11 Mar 2010

AAOS 2010 meeting highlights emerging incidence of pediatric sports injuries

At today's 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), two separate studies focus on the dramatic rise of pediatric sports injuries in recent years. However, despite this alarming trend, awareness, education, warning signs and early treatment can make a significant difference and help keep these athletes in the game, according to the study experts.

11 Mar 2010

Cytokeratins 8 and 18 can strongly enhance breast cancer drug fulvestrant's anti-estrogenic activity

Women's responsiveness to the second-line breast cancer drug fulvestrant may depend on whether the cancer cells are expressing two key proteins, Indiana University Bloomington scientists report in this month's Cancer Biology & Therapy.

11 Mar 2010

FDA sponsoring workshops to increase rare disease treatment options

The Wall Street Journal: FDA is putting on workshops for pharmaceutical manufacturers to increase the pool of applicants for approved "orphan drugs," that treat rare diseases. Currently, there are about 7,000 so-called orphan diseases in the U.S. that have few or no FDA-approved treatments.

11 Mar 2010

Mayo Clinic to form new permanent professorship for cancer research

Mayo Clinic is forming a new permanent professorship to augment cancer research that will focus on finding new treatments and preventive measures to reduce the incidence of cancer.

11 Mar 2010

Clinical trial shows eprotirome drug reduces blood cholesterol

A thyroid-hormone-like substance that works specifically on the liver reduces blood cholesterol with no serious side effects. This according to a clinical trial conducted by researchers from the Swedish medical university Karolinska Institutet, amongst other centres, published today in the top-ranking scientific periodical The New England Journal of Medicine.

11 Mar 2010

Cogent Healthcare, Seton Medical Center to develop exclusive hospitalist care delivery system

Cogent Healthcare today announced a new hospital medicine affiliation with 375-bed Seton Medical Center, located in Daly City, Calif., and the Daly City Hospitalist Medical Group, an existing Seton physician group, to develop a distinctive hospitalist care delivery system.

11 Mar 2010

Patients who undergo gastric bypass surgery increase their risk of developing kidney stones

Patients who undergo gastric bypass surgery experience changes in their urine composition that increase their risk of developing kidney stones, research from UT Southwestern Medical Center investigators suggests.

10 Mar 2010

Small study shows eprotirome decreases LDL cholesterol

People whose "bad" cholesterol and risk of future heart disease stay too high despite cholesterol-lowering statin therapy can safely lower it by adding a drug that mimics the action of thyroid hormone. In a report published in the Mar. 11, issue of the New England Journal of Medicine, Johns Hopkins and Swedish researchers say an experimental drug called eprotirome lowered cholesterol up to 32 percent in those already on statins, an effect equal to that expected from doubling the statin drug doses, without harmful side effects.

10 Mar 2010

Medical school costs, loan rates rise sharply

NPR reports on the high cost of medical school, focusing on one student, Sarah Rosen. The interest rate on her school loans "shot up to eight and a half percent, almost twice the rate [her parents] are paying after refinancing their mortgage."

10 Mar 2010

Discovery Laboratories reports net loss of $6.1M for fourth-quarter 2009

Discovery Laboratories, Inc. today announces financial results for the fourth quarter ended December 31, 2009 and provides a business update.

10 Mar 2010

Today's OpEds: Congressional dealmaking, cutting 'honchos pay,' controlling costs

Legislators need pork to make things happen, especially in an age when chronic obstruction has so weakened the legislative process that policy breakthroughs are almost impossible. This does not excuse all kinds of deal making, nor should we ignore that deals sometimes go too far (Julian E. Zelizer, 3/10).

10 Mar 2010

Eprotirome lowers bad cholesterol, triglycerides and Lp(A) without statin side effects

A new drug, eprotirome, has been shown to significantly lower bad cholesterol, triglycerides and Lp(A), without the side effects that statins cause in many people. Results of a study were published today in the New England Journal of Medicine.

10 Mar 2010

Medicine News and Research

AAA approves guidelines to accept donation of bodies for education and biomedical research

Scientists identify specific causative genetic mutation associated with CMT

Molecular master switch plays a key role in maturation process of brain cells

Forteo therapy may speed healing, improve patient outcomes after rotator cuff surgery

Insight Imaging commences operations in partnership with ARA in the Dallas metro-area

ABH to host three events featuring Dermagraft at DF Con 2010

RTI Biologics launches BTB Select and BioCAP Select implants for use in sports medicine surgeries at AAOS 2010

New study shows e-prescriptions reduce medication errors

AAOS 2010 meeting highlights emerging incidence of pediatric sports injuries

Cytokeratins 8 and 18 can strongly enhance breast cancer drug fulvestrant's anti-estrogenic activity

FDA sponsoring workshops to increase rare disease treatment options

Mayo Clinic to form new permanent professorship for cancer research

Clinical trial shows eprotirome drug reduces blood cholesterol

Cogent Healthcare, Seton Medical Center to develop exclusive hospitalist care delivery system

Patients who undergo gastric bypass surgery increase their risk of developing kidney stones

Small study shows eprotirome decreases LDL cholesterol

Medical school costs, loan rates rise sharply

Discovery Laboratories reports net loss of $6.1M for fourth-quarter 2009

Today's OpEds: Congressional dealmaking, cutting 'honchos pay,' controlling costs

Eprotirome lowers bad cholesterol, triglycerides and Lp(A) without statin side effects

Everything there is to know about biosimilars eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News